Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Wang, Chih Yang ^a,b   Lai, Ming Derg ^b   Phan, Nam Nhut ^c   Sun, Zhengda ^d   Lin, Yen Chang ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TON DUC THANG UNIVERSITY   (Viet Nam)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL CAV1.1; CALCIUM CHANNEL CAV1.2; CALCIUM CHANNEL CAV1.3; CALCIUM CHANNEL CAV1.4; CALCIUM CHANNEL CAV2.1; CALCIUM CHANNEL CAV2.2; CALCIUM CHANNEL CAV2.3; CALCIUM CHANNEL CAV3.1; CALCIUM CHANNEL CAV3.2; CALCIUM CHANNEL CAV3.3; MESSENGER RNA; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; CALCIUM CHANNEL;

ARTICLE; BIOINFORMATICS; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; DATA BASE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; LYMPHOMA; MICROARRAY ANALYSIS; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; SARCOMA; SKIN CANCER; STOMACH CANCER; TESTIS CANCER; UPREGULATION; UTERINE CERVIX CANCER; UTERUS CANCER; VGCC GENE; CHANNEL GATING; GENETICS; INFORMATION PROCESSING; META ANALYSIS; NEOPLASM;

CALCIUM CHANNELS; DATASETS AS TOPIC; HUMANS; ION CHANNEL GATING; NEOPLASMS;

EID: 84940175330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125766     Document Type: Article

References (142)

1. Prevarskaya N, Skryma R, Shuba Y. Ion channels and the hallmarks of cancer. Trends in molecular medicine. 2010; 16(3):107-21. doi: 10.1016/j.molmed.2010.01.005 PMID: 20167536
2. Lipskaia L, Lompré AM. Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biology of the Cell. 2004; 96(1):55-68. PMID: 15093128
3. Schreiber R. Ca2+ signaling, intracellular pH and cell volume in cell proliferation. The Journal of membrane biology. 2005; 205(3):129-37. PMID: 16362501
4. Panner A, Wurster RD. T-type calcium channels and tumor proliferation. Cell calcium. 2006; 40(2):253-9. PMID: 16765439
5. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002; 415(6870):436-42. PMID: 11807556
6. Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR. Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation. Nature genetics. 2004; 36(3):257-63. PMID: 14770183
7. Grasso CS, Wu Y- M, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012; 487(7406):239-43. doi: 10.1038/nature11125 PMID: 22722839
8. Storz MN, van de Rijn M, Kim YH, Mraz-Gernhard S, Hoppe RT, Kohler S. Gene expression profiles of cutaneous B cell lymphoma. J Invest Dermatol. 2003; 120(5):865-70. doi: 10.1046/j.1523-1747.2003.12142.x PMID: WOS:000182456200027.
9. Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer research. 2008; 68(13):5478-86. doi: 10.1158/0008-5472.CAN-07-6595 PMID: 18593951
10. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, DeCarolis PL, et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nature genetics. 2010; 42(8):715-21. doi: 10.1038/ng.619 PMID: 20601955
11. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer research. 2005; 65(13):5588-98. PMID: 15994931
12. Cutcliffe C, Kersey D, Huang C-C, Zeng Y, Walterhouse D, Perlman EJ. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clinical cancer research. 2005; 11(22):7986-94. PMID: 16299227
13. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nature medicine. 2008; 14(5):518-27. doi: 10.1038/nm1764 PMID: 18438415
14. Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer research. 2009; 69(15):6171-8. doi: 10.1158/0008-5472.CAN-08-4471 PMID: 19622772
15. Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology. 2006; 131(3):925-33. PMID: 16952561
16. Szatkowski C, Parys JB, Ouadid-Ahidouch H, Matifat F. Inositol 1,4,5-trisphosphate-induced Ca(2+) signalling is involved in estradiol-induced breast cancer epithelial cell growth. Molecular Cancer. 2010; 9:156. doi: 10.1186/1476-4598-9-156 PMC2906470. PMID: 20565939
17. Mariot P, Prevarskaya N, Roudbaraki MM, Le Bourhis X, Van Coppenolle F, Vanoverberghe K, et al. Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells. The Prostate. 2000; 43(3):205-14. PMID: 10797495
18. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacological reviews. 2005; 57(4):411-25. PMID: 16382099
19. Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacological Reviews. 2003; 55(4):579-81. PMID: 14657414
20. Tang S, Yatan A, Bahinski A, Mori Y, Schwartz A. Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action. Neuron. 1993; 11(6):1013-21. PMID: 8274273
21. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002; 415(6868):198-205. PMID: 11805843
22. Tanabe T, Beam KG, Adams BA, Niidome T, Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature. 1990; 346(6284):567-9. PMID: 2165570
23. Gomez A, Valdivia H, Cheng H, Lederer MR, Santana L, Cannell M, et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997; 276(5313):800-6. PMID: 9115206
24. Olivera BM, Miljanich G, Ramachandran J, Adams ME. Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins. Annual review of biochemistry. 1994; 63(1):823-67.
25. Uchitel O, Protti D, Sanchez V, Cherksey B, Sugimori M, Llinas R. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proceedings of the National Academy of Sciences. 1992; 89(8):3330-3.
26. Ayata C, Shimizu-Sasamata M, Lo E, Noebels J, Moskowitz M. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the α1A subunit of P/Q type calcium channels. Neuroscience. 1999; 95(3):639-45.
27. Codignola A, Tarroni P, Clementi F, Pollo A, LoVallo M, Carbone E, et al. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. Journal of Biological Chemistry. 1993; 268(35):26240-7. PMID: 8253745
28. Mermelstein PG, Becker JB, Surmeier DJ. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. Journal of Neuroscience. 1996; 16(2):595-604. PMID: 8551343
29. Catterall WA. Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium. 1998; 24(5-6):307-23. doi: http://dx.doi.org/10.1016/S0143-4160(98)90055-0. PMID: 10091001
30. Boland LM, Bean BP. Modulation of N-type calcium channels in bullfrog sympathetic neurons by luteinizing hormone-releasing hormone: kinetics and voltage dependence. The Journal of neuroscience. 1993; 13(2):516-33. PMID: 7678856
31. Westenbroek RE, Hell JW, Warner C, Dubel SJ, Snutch TP, Catterall WA. Biochemical properties and subcellular distribution of an N-type calcium hannel α1 subunit. Neuron. 1992; 9(6):1099-115. PMID: 1334419
32. Mackie K, Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proceedings of the National Academy of Sciences. 1992; 89(9):3825-9.
33. Diverse-Pierluissi M, Goldsmith PK, Dunlap K. Transmitter-mediated inhibition of N-type calcium channels in sensory neurons involves multiple GTP-binding proteins and subunits. Neuron. 1995; 14(1):191-200. PMID: 7826637
34. Markram H, Helm PJ, Sakmann B. Dendritic calcium transients evoked by single back-propagating action potentials in rat neocortical pyramidal neurons. The Journal of physiology. 1995; 485(Pt 1):1-20.
35. Yasuda R, Sabatini BL, Svoboda K. Plasticity of calcium channels in dendritic spines. Nature neuroscience. 2003; 6(9):948-55. PMID: 12937422
36. Johnston D, Magee JC, Colbert CM, Christie BR. Active properties of neuronal dendrites. Annual review of neuroscience. 1996; 19(1):165-86.
37. Carlin K, Jones K, Jiang Z, Jordan L, Brownstone R. Dendritic L-type calcium currents in mouse spinal motoneurons: implications for bistability. European Journal of Neuroscience. 2000; 12(5):1635-46. PMID: 10792441
38. Perez-Reyes E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiological Reviews. 2003; 83(1):117-61. PMID: 12506128
39. Bohn G, Moosmang S, Conrad H, Ludwig A, Hofmann F, Klugbauer N. Expression of T-and L-type calcium channel mRNA in murine sinoatrial node. FEBS letters. 2000; 481(1):73-6. PMID: 10984618
40. Cribbs LL, Lee J-H, Yang J, Satin J, Zhang Y, Daud A, et al. Cloning and characterization of α1H from human heart, a member of the T-type Ca2+ channel gene family. Circulation Research. 1998; 83(1):103-9. PMID: 9670923
41. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, et al. Nomenclature of voltage-gated calcium channels. Neuron. 2000; 25(3):533-5. PMID: 10774722
42. Huguenard J, Prince D. A novel T-type current underlies prolonged Ca (2+)-dependent burst firing in GABAergic neurons of rat thalamic reticular nucleus. The Journal of neuroscience. 1992; 12(10):3804-17. PMID: 1403085
43. Kito M, Maehara M, Watanabe K. Mechanisms of T-type calcium channel blockade by zonisamide. Seizure. 1996; 5(2):115-9. PMID: 8795126
44. Hoheisel JD. Microarray technology: beyond transcript profiling and genotype analysis. Nature reviews genetics. 2006; 7(3):200-10. PMID: 16485019
45. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007; 9(2):166-80. PMID: 17356713
46. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform. Neoplasia. 2004; 6(1):1-6. doi: http://dx.doi.org/10.1016/S1476-5586(04)80047-2. PMID: 15068665
47. Ewald JA, Downs TM, Cetnar JP, Ricke WA. Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma. PloS one. 2013; 8(2):e55414. doi: 10.1371/journal.pone.0055414 PMID: 23383328
48. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009; 151(4):264-9. PMID: 19622511
49. Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, Imai Y, et al. Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer cell. 2011; 20(1):119-31. doi: 10.1016/j.ccr.2011.05.026 PMID: 21741601
50. D'Ambrogio A, Nagaoka K, Richter JD. Translational control of cell growth and malignancy by the CPEBs. Nature Reviews Cancer. 2013; 13(4):283-90. doi: 10.1038/nrc3485 PMID: 23446545
51. Gyorffy B, Lanczky A, Szallasi Z. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr-Relat Cancer. 2012; 19(2):197-208. doi: 10.1530/Erc-11-0329 PMID: WOS:000303539700011.
52. Gyorffy B, Benke Z, Lanczky A, Balazs B, Szallasi Z, Timar J, et al. RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data. Breast Cancer Res Tr. 2012; 132(3):1025-34. doi: 10.1007/s10549-011-1676-y PMID: WOS:000303379800025.
53. Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer. Plos One. 2013; 8(12). doi: UNSP e82241 doi: 10.1371/journal.pone.0082241 PMID: WOS:000328740300023.
54. Berridge MJ. Calcium signalling and cell proliferation. Bioessays. 1995; 17(6):491-500. PMID: 7575490
55. Dziegielewska B, Brautigan DL, Larner JM, Dziegielewski J. T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells. Molecular Cancer Research. 2014; 12(3):348-58. doi: 10.1158/1541-7786.MCR-13-0485 PMID: 24362252
56. Lee JY, Park SJ, Park SJ, Lee MJ, Rhim H, Seo SH, et al. Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers. Bioorganic & medicinal chemistry letters. 2006; 16(19):5014-7.
57. Triggle DJ. Calcium channel antagonists: clinical uses - past, present and future. Biochemical pharmacology. 2007; 74(1):1-9. PMID: 17276408
58. Dziegielewska B, Gray LS, Dziegielewski J. T-type calcium channels blockers as new tools in cancer therapies. Pflügers Archiv-European Journal of Physiology. 2014; 466(4):801-10. doi: 10.1007/s00424-014-1444-z PMID: 24449277
59. Taylor JT, Zeng X-B, Pottle JE, Lee K, Wang AR, Yi SG, et al. Calcium signaling and T-type calcium channels in cancer cell cycling. World journal of gastroenterology: WJG. 2008; 14(32):4984. PMID: 18763278
60. Lee KS, Tsien RW. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 1983; 302(5911):790-4. PMID: 6302512
61. Weiss J, Hartley D, Koh J-Y, Choi D. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science(Washington). 1990; 247(4949):1474-7.
62. Haverstick DM, Heady TN, Macdonald TL, Gray LS. Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer research. 2000; 60(4):1002-8. PMID: 10706116
63. Enfissi A, Prigent S, Colosetti P, Capiod T. The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell calcium. 2004; 36(6):459-67. PMID: 15488595
64. Chung SC, McDonald TV, Gardner P. Inhibition by SK&F 96365 of Ca2+ current, IL-2 production and activation in T lymphocytes. British journal of pharmacology. 1994; 113(3):861-8. PMID: 7858878
65. Azimi I, Roberts-Thomson S, Monteith G. Calcium influx pathways in breast cancer: opportunities for pharmacological intervention. British journal of pharmacology. 2014; 171(4):945-60. doi: 10.1111/bph.12486 PMID: 24460676
66. Loughlin KR. Calcium channel blockers and prostate cancer. Urologic Oncology: Seminars and Original Investigations. 2014; 32(5):537-8. doi: http://dx.doi.org/10.1016/j.urolonc.2013.08.001. doi: 10.1016/j.urolonc.2013.08.001 PMID: 24814406
67. Zhuang L, Peng J-B, Tou L, Takanaga H, Adam RM, Hediger MA, et al. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Laboratory investigation. 2002; 82(12):1755-64. PMID: 12480925
68. Hall DD, Wu Y, Domann FE, Spitz DR, Anderson ME. Mitochondrial Calcium Uniporter Activity Is Dispensable for MDA-MB-231 Breast Carcinoma Cell Survival. PloS one. 2014; 9(5):e96866.
69. Cain SM, Snutch TP. Voltage-gated calcium channels and disease. Biofactors. 2011; 37(3):197-205. doi: 10.1002/biof.158 PMID: 21698699
70. Bidaud I, Mezghrani A, Swayne LA, Monteil A, Lory P. Voltage-gated calcium channels in genetic diseases. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2006; 1763(11):1169-74.
71. Kamp TJ, Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circulation research. 2000; 87(12):1095-102. PMID: 11110765
72. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, et al. Dominant role of smooth muscle L-type calcium channel Cav1. 2 for blood pressure regulation. The EMBO Journal. 2003; 22(22):6027-34. PMID: 14609949
73. Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One. 2010; 5(10):e13091. doi: 10.1371/journal.pone.0013091 PMID: 20957034
74. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, et al. Transcriptome profile of human colorectal adenomas. Molecular cancer research: MCR. 2007; 5(12):1263-75. doi: 10.1158/1541-7786.MCR-07-0267 PMID: 18171984.
75. Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, et al. Gene expression signature-based prognostic risk score in gastric cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2011; 17(7):1850-7. doi: 10.1158/1078-0432.CCR-10-2180 PMID: 21447720; PubMed Central PMCID: PMC3078023.
76. D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, et al. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. European journal of cancer. 2009; 45(3):461-9. doi: doi: 10.1016/j.ejca.2008.10.032 PMID: 19081245.
77. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003; 63(10):2649-57. PMID: 12750293.
78. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res. 2005; 65(13):5881-9. doi: 10.1158/0008-5472.CAN-04-4078 PMID: 15994966.
79. Coustan-Smith E, Song G, Clark C, Key L, Liu P, Mehrpooya M, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011; 117(23):6267-76. doi: 10.1182/blood-2010-12-324004 PMID: 21487112; PubMed Central PMCID: PMC3122946.
80. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9(5):391-403. doi: 10.1016/j.ccr.2006.03.030 PMID: 16697959.
81. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, et al. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 2005; 65(19):8679-89. doi: 10.1158/0008-5472.CAN-05-1204 PMID: 16204036.
82. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012; 486(7403):346-52. doi: 10.1038/nature10983 PMID: 22522925; PubMed Central PMCID: PMC3440846.
83. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 2007; 7:55. doi: 10.1186/1471-2407-7-55 PMID: 17389037; PubMed Central PMCID: PMC1852112.
84. Quade BJ, Wang TY, Sornberger K, Dal Cin P, Mutter GL, Morton CC. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes, chromosomes & cancer. 2004; 40(2):97-108. doi: 10.1002/gcc.20018 PMID: 15101043.
85. Nindl I, Dang C, Forschner T, Kuban RJ, Meyer T, Sterry W, et al. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer. 2006; 5:30. doi: 10.1186/1476-4598-5-30 PMID: 16893473; PubMed Central PMCID: PMC1569867.
86. LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002; 62(15):4499-506. PMID: 12154061.
87. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A. 2004; 101(3):811-6. doi: 10.1073/pnas.0304146101 PMID: 14711987; PubMed Central PMCID: PMC321763.
88. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22. doi: 10.1016/j.ccr.2010.05.026 PMID: 20579941; PubMed Central PMCID: PMC3198787.
89. Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, et al. Integrative molecular concept modeling of prostate cancer progression. Nat Genet. 2007; 39(1):41-51. doi: doi: 10.1038/ng1935 PMID: 17173048.
90. Vanaja DK, Cheville JC, Iturria SJ, Young CY. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res. 2003; 63(14):3877-82. PMID: 12873976.
91. Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, et al. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 2006; 66(8):4011-9. doi: 10.1158/0008-5472.CAN-05-3055 PMID: 16618720.
92. Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera JM, et al. Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009; 15(18):5794-802. doi: 10.1158/1078-0432.CCR-09-0911 PMID: 19737960.
93. Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 2008; 68(3):927-36. doi: 10.1158/0008-5472.CAN-07-2608 PMID: 18245496.
94. Luo JH, Yu YP, Cieply K, Lin F, Deflavia P, Dhir R, et al. Gene expression analysis of prostate cancers. Mol Carcinogen. 2002; 33(1):25-35. doi: 10.1002/Mc.10018 PMID: WOS:000173276900004.
95. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Research. 2001; 61(15):5692-6. PMID: WOS:000170194700003.
96. Radvanyi L, Singh-Sandhu D, Gallichan S, Lovitt C, Pedyczak A, Mallo G, et al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(31):11005-10. doi: 10.1073/pnas.0500904102 PMID: WOS:000231102400050.
97. Dyrskjot L, Kruhoffer M, Thykjaer T, Marcussen N, Jensen JL, Moller K, et al. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res. 2004; 64(11):4040-8. doi: 10.1158/0008-5472.CAN-03-3620 PMID: 15173019.
98. Cui JA, Chen YB, Chou WC, Sun LK, Chen L, Suo JA, et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res. 2011; 39(4):1197-207. doi: 10.1093/Nar/Gkq960 PMID: WOS:000288019400010.
99. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 2001; 98(24):13790-5. doi: 10.1073/pnas.191502998 PMID: 11707567; PubMed Central PMCID: PMC61120.
100. Bhat S, Dao DT, Terrillion CE, Arad M, Smith RJ, Soldatov NM, et al. CACNA1C (Ca(v)1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol. 2012; 99(1):1-14. doi: 10.1016/j.pneurobio.2012.06.001 PMID: WOS:000310171800001.
101. Chambers KF, Pearson JF, Pellacani D, Aziz N, Gužvić M, Klein CA, et al. Stromal upregulation of lateral epithelial adhesions: Gene expression analysis of signalling pathways in prostate epithelium. Journal of biomedical science. 2011; 18(1):1-13.
102. Szatkowski C, Parys JB, Ouadid-Ahidouch H, Matifat F. Inositol 1, 4, 5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Molecular Cancer. 2010; 9(1):156.
103. Pesch K, Zeitz C, Fries JE, Münscher S, Pusch CM, Kohler K, et al. Isolation of the mouse nyctalopin gene nyx and expression studies in mouse and rat retina. Investigative ophthalmology & visual science. 2003; 44(5):2260-6.
104. Llinas R, Sugimori M, Lin J, Cherksey B. Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison. Proceedings of the National Academy of Sciences. 1989; 86(5):1689-93.
105. Randall A, Tsien RW. Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. The Journal of neuroscience. 1995; 15(4):2995-3012. PMID: 7722641
106. Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, et al. Splicing of α1A subunit gene generates phenotypic variants of P-and Q-type calcium channels. Nature neuroscience. 1999; 2(5):407-15. PMID: 10321243
107. Chaudhuri D, Chang S-Y, DeMaria CD, Alvania RS, Soong TW, Yue DT. Alternative splicing as a molecular switch for Ca2+/calmodulin-dependent facilitation of P/Q-type Ca2+ channels. The Journal of neuroscience. 2004; 24(28):6334-42. PMID: 15254089
108. Gazulla J, Tintore M. P/Q-type voltage-dependent calcium channels in neurological disease. Neurologia. 2007; 22(8):511-6. PMID: WOS:000251211500004.
109. Guida S, Trettel F, Pagnutti S, Mantuano E, Tottene A, Veneziano L, et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. The American Journal of Human Genetics. 2001; 68(3):759-64.
110. Battistini S, Stenirri S, Piatti M, Gelfi C, Righetti P, Rocchi R, et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology. 1999; 53(1):38-. PMID: 10408534
111. Segarra NG, Gautschi I, Mittaz-Crettol L, Zetchi CK, Al-Qusairi L, Van Bemmelen MX, et al. Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A. Journal of the neurological sciences. 2014; 342(1):69-78.
112. Kono S, Terada T, Ouchi Y, Miyajima H. An altered GABA-A receptor function in spinocerebellar ataxia type 6 and familial hemiplegic migraine type 1 associated with the CACNA1A gene mutation. BBA Clinical. 2014; 2:56-61.
113. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clinical Cancer Research. 2008; 14(16):5198-208. doi: 10.1158/1078-0432.Ccr-08-0196 PMID: WOS:000258523800025.
114. Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Bene MC, et al. Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group. J Clin Oncol. 2010; 28(15):2529-37. doi: 10.1200/Jco.2009.23.4732 PMID: WOS:000277832400007.
115. Zhan FH, Barlogie B, Arzoumanian V, Huang YS, Hollmig K, Pineda-Roman M, et al. A gene expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood. 2006; 108(11):969a-a. PMID: WOS:000242440004441.
116. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC medical genomics. 2008; 1(1):13.
117. Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, et al. Gene expression analysis of Preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Research. 2007; 67(21):10163-72. doi: 10.1158/0008-5472.Can-07-2056 PMID: WOS:000250700200011.
118. Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer research. 2001; 61(20):7388-93. PMID: 11606367
119. Su L-J, Chang C-W, Wu Y-C, Chen K-C, Lin C-J, Liang S-C, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC genomics. 2007; 8(1):140.
120. Varambally S, Yu JJ, Laxman B, Rhodes DR, Mehra R, Tomlins SA, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell. 2005; 8(5):393-406. doi: 10.1016/j.ccr.2005.10.001 PMID: WOS:000233502600007.
121. Lory P, Bidaud I, Chemin J. T-type calcium channels in differentiation and proliferation. Cell calcium. 2006; 40(2):135-46. PMID: 16797068
122. Bertolesi GE, Shi C, Elbaum L, Jollimore C, Rozenberg G, Barnes S, et al. The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Molecular pharmacology. 2002; 62(2):210-9. PMID: 12130671
123. Chambers AF, Groom AC, MacDonald IC. Metastasis: dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer. 2002; 2(8):563-72. PMID: 12154349
124. Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L. Tumor development under angiogenic signaling a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer research. 1999; 59(19):4770-5. PMID: 10519381
125. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research. 2004; 10(20):6897-904. PMID: 15501967
126. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002; 296(5574):1883-6. PMID: 11976409
127. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nature reviews Molecular cell biology. 2009; 10(7):445-57. doi: 10.1038/nrm2720 PMID: 19546857
128. Weigelt B, Peterse JL, Van't Veer LJ. Breast cancer metastasis: markers and models. Nature reviews cancer. 2005; 5(8):591-602. PMID: 16056258
129. Winston CB, Hadar O, Teitcher JB, Caravelli JF, Sklarin NT, Panicek DM, et al. Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. American Journal of Roentgenology. 2000; 175(3):795-800. PMID: 10954469
130. Borst M, Ingold J. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery. 1993; 114(4):637-41; discussion 41-2. PMID: 8211676
131. Harris M, Howell A, Chrissohou M, Swindell R, Hudson M, Sellwood R. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. British journal of cancer. 1984; 50(1):23. PMID: 6331484
132. Luo W, Chang R, Zhong J, Pandey A, Semenza GL. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proceedings of the National Academy of Sciences. 2012; 109(49):E3367-E76.
133. Shinagare AB, Ramaiya NH, Jagannathan JP, Fennessy FM, Taplin M-E, Van den Abbeele AD. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. American Journal of Roentgenology. 2011; 196(1):117-22. doi: 10.2214/AJR.10.5036 PMID: 21178055
134. Schuchert MJ, Luketich JD. Solitary sites of metastatic disease in non-small cell lung cancer. Current treatment options in oncology. 2003; 4(1):65-79. PMID: 12525281
135. Coghlin C, Murray GI. Current and emerging concepts in tumour metastasis. The Journal of pathology. 2010; 222(1):1-15. doi: 10.1002/path.2727 PMID: 20681009
136. Aragon-Ching JB, Zujewski JA. CNS metastasis: an old problem in a new guise. Clinical Cancer Research. 2007; 13(6):1644-7. PMID: 17363516
137. Javier BV, Yount WJ, Crosby DJ, Hall TC. Cardiac metastasis in lymphoma and leukemia. CHEST Journal. 1967; 52(4):481-4.
138. Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A, et al. Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. European journal of heart failure. 2009; 11(2):140-6. doi: 10.1093/eurjhf/hfn026 PMID: 19168511
139. Chen R, Zeng X, Zhang R, Huang J, Kuang X, Yang J, et al. Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers. Urologic Oncology: Seminars and Original Investigations. 2014; 32(5):524-36. doi: http://dx.doi.org/10.1016/j.urolonc.2013.05.011. doi: 10.1016/j.urolonc.2013.05.011 PMID: 24054868
140. Choi DL, Jang SJ, Cho S, Choi H-E, Rim H-K, Lee K-T, et al. Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist. Bioorganic & medicinal chemistry letters. 2014; 24(6):1565-70.
141. Chen Q, Zhang Q, Zhong F, Guo S, Jin Z, Shi W, et al. Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies. Pharmacoepidemiology and Drug Safety. 2014; 23(7):711-8. doi: 10.1002/pds.3645 PMID: 24829113
142. Pierro C, Cook SJ, Foets TC, Bootman MD, Roderick HL. Oncogenic K-Ras suppresses IP3-dependent Ca2+ release through remodelling of the isoform composition of IP3Rs and ER luminal Ca2+ levels in colorectal cancer cell lines. Journal of cell science. 2014; 127(7):1607-19.